Enjoy complimentary customisation on priority with our Enterprise License!
The atrial fibrillation surgery market size is forecast to increase by USD 1.99 billion at a CAGR of 14.76% between 2023 and 2028. The market is experiencing significant growth due to the increasing prevalence of cardiovascular disorders, particularly rhythm disturbances such as atrial fibrillation. This condition can lead to acute cardiac events, including shock and acute respiratory distress, making effective treatment a priority. Surgical procedures, including catheter ablation, have emerged as viable options for managing atrial fibrillation. However, the high cost of ablation catheters and the need for specialized expertise and facilities pose challenges to widespread adoption. Additionally, advances in technology, such as digital catheterization labs in hospitals, are driving competition and improving patient outcomes. Despite these advancements, the market remains competitive, with ongoing research and development efforts aimed at reducing treatment costs and improving patient care.
Atrial fibrillation (AF), a common heart rhythm disorder, affects millions of people worldwide. According to the American Heart Association, AF accounts for over 2.7 million cases in the US alone. This condition, characterized by irregular and often rapid heartbeats, increases the risk of stroke, heart failure, and other complications. The AF surgery market encompasses various procedures aimed at restoring normal heart rhythm. These procedures include catheter ablation and surgical ablation. Catheter ablation involves using a catheter to deliver energy to the heart to destroy small areas of heart tissue that cause irregular heartbeats.
In addition, surgical ablation, on the other hand, is an open-heart procedure where surgeons use heat or cold energy to remove the affected heart tissue. Regulatory policies and data requirements play a crucial role in the AF surgery market. The US Food and Drug Administration (FDA) regulates the approval and use of medical devices and procedures related to AF surgery. These regulatory requirements ensure the safety and efficacy of AF surgery procedures. The cost of AF surgery is a significant factor influencing the market. The cost of catheter ablation and surgical ablation varies depending on the specific procedure, hospital location, and patient's insurance coverage.
Additionally, continuous data collection and analysis can help improve treatment outcomes and reduce healthcare costs. The AF surgery market faces regulatory issues related to skilled labor and reimbursement policies. The shortage of skilled labor, particularly in rural areas, can limit access to AF surgery procedures. Reimbursement policies also play a role in the market, as some insurers may not cover the full cost of AF surgery procedures, making them less accessible to some patients. In conclusion, the AF surgery market is driven by the increasing prevalence of AF and the need for effective treatment options. Regulatory policies and data requirements ensure the safety and efficacy of AF surgery procedures, while advanced technologies such as remote patient monitoring and continuous data analysis are transforming the market. The cost of AF surgery and the availability of skilled labor remain significant challenges for the market.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
The catheter ablation segment is estimated to witness significant growth during the forecast period. Atrial fibrillation, a type of cardiac arrhythmia, is characterized by an irregular and often rapid heart rhythm. This condition, which affects the electrical systems regulating the heart, can lead to symptoms such as chest pain, shortness of breath, fatigue, dizziness, and fainting. The prevalence of atrial fibrillation is increasing, driven in part by the aging population and the rising incidence of cardiovascular disorders, including myocarditis, rhythm disturbances, acute cardiac shock, and acute respiratory distress. The growing number of cases and the resulting demand for effective treatments have fueled the growth of the market. One of the most common treatments for this condition is catheter ablation, a non-surgical procedure that uses heat or cold to scar the heart tissue responsible for the abnormal rhythm.
In addition, the market for catheter ablation equipment and services is expected to continue growing at a significant rate due to the increasing number of procedures being performed. Despite the advances in treatment options, atrial fibrillation remains a complex and challenging condition to manage. The high cost of treatment, including hospitalization, medication, and follow-up care, can be a barrier to access for many patients. As a result, there is ongoing research and development aimed at improving the safety, efficacy, and affordability of atrial fibrillation treatments. In conclusion, the increasing prevalence of atrial fibrillation and the growing demand for effective treatments have driven the growth of the market.
Furthermore, catheter ablation, a non-surgical procedure for treating this condition, is a key contributor to this market's growth. Despite the advances in treatment options, the high cost of care remains a significant challenge for many patients. Ongoing research and development efforts are focused on improving the safety, efficacy, and affordability of atrial fibrillation treatments.
Get a glance at the market share of various segments Request Free Sample
The catheter ablation segment accounted for USD 940.20 million in 2018 and showed a gradual increase during the forecast period.
North America is estimated to contribute 39% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market share of various regions Request Free Sample
The North American region is expected to lead the market due to a rising patient population and economic growth. According to the Centers for Disease Control and Prevention (CDC), approximately 2.7 to 6.1 million Americans had atrial fibrillation in 2017, and this number is projected to increase with the aging population. Atherosclerosis, or hardening of the arteries, is a leading cause of atrial fibrillation, accounting for 14-22% of all cases in the US, as per the American Heart Association (2018). Peerbridge Health and Northwell Health are some of the key players in the atrial fibrillation therapeutics market in the US.
Furthermore, isolator Synergy, a subsidiary of Medtronic, offers the AtriCure Isolator Synergy Ablation System for the treatment of atrial fibrillation. Regulatory issues and the requirement for skilled labor pose challenges to market growth. Heart failure and obstructive sleep apnea (OSA) are other conditions associated with atrial fibrillation, further increasing the demand for effective treatments. As per the American Heart Association, heart failure affects around 6.5 million Americans, and the prevalence of OSA is estimated to be around 22 million. In conclusion, the market in the US is driven by the growing patient population, technological advancements, and the presence of key players.
However, regulatory hurdles and the need for skilled labor pose challenges to market growth. The increasing prevalence of associated conditions such as heart failure and OSA is expected to further fuel demand for atrial fibrillation therapeutics.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Advances in technology is the key driver of the market. The market for atrial fibrillation surgery has witnessed significant advancements, with companies focusing on minimally invasive procedures to reduce surgical pain, injury, and hospital stay. Next-generation ablation catheters, such as Boston Scientific's IntellaTip MiFi XP Temperature Ablation Catheter, are leading the way with their precision and speedy recovery benefits. These advanced devices feature smaller electrodes that provide more accurate information of the ablation area, improving the overall effectiveness of the procedure. The MiFi sensor technology embedded in the catheter's tip offers high-resolution imaging of heart tissues, enabling surgeons to precisely locate the arrhythmia. HST Pathways and Accredited Surgical Centers (ASCs) are increasingly adopting these customized services to offer better patient outcomes and reduce healthcare costs.
Furthermore, HST One, a leading provider of these services, ensures a streamlined process from pre-procedure planning to post-procedure follow-up care. By focusing on patient-centric solutions, companies in this market continue to innovate and improve the atrial fibrillation surgery experience.
Emergence of digital catheterization labs in hospitals is the upcoming trend in the market. Atrial arrhythmia, specifically atrial fibrillation (AF), is a common heart rhythm disorder that affects millions of individuals worldwide. The American Heart Association reports an increasing number of AF cases, leading to a growing demand for effective treatment methods. AF surgery, including catheter ablation and surgical ablation, has emerged as a viable solution for managing this condition. Regulatory policies and data requirements ensure the safety and efficacy of these procedures. Cath labs or cardiac catheterization laboratories play a crucial role in the diagnosis and treatment of AF. These facilities, located in hospitals, conduct both diagnostic and therapeutic procedures using advanced catheterization technology.
In addition, robot-assisted catheterization, for instance, enhances digital imaging systems, enabling better detection and intervention of cardiac diseases. High-quality flat panels are widely utilized in hospitals for most cardiovascular and peripheral catheterization procedures. Diagnostic services for outpatient procedures in hospitals, ambulatory surgery centers (ASCs), and physicians' clinics are the primary focus of these laboratories. Their expertise in this area ensures accurate diagnoses and effective treatments for patients, ultimately improving patient outcomes. By adhering to professional standards and maintaining a commitment to continuous improvement, these laboratories contribute significantly to the healthcare industry's efforts to manage the increasing prevalence of atrial arrhythmias.
High cost of ablation catheters is a key challenge affecting the market growth. In the healthcare industry, hospitals and medical centers face the challenge of delivering high-quality care while managing costs, particularly in the context of advanced procedures such as catheter ablation for treating arrhythmias like Atrial Fibrillation (AFib). These procedures require sophisticated devices, including LAAC (Left Atrial Appendage Closure) devices for stroke prevention and those enabled with technologies like 3D mapping and remote catheter navigation for effective ablation strategies. The implementation of such advanced devices comes with significant investment and maintenance costs. Therefore, medical institutions must carefully consider their procurement processes and budget allocations. Moreover, maintaining the devices in optimal working condition is crucial to ensure the success of ablation procedures and improve patient outcomes.
Furthermore, one such advanced device is the CathVision system, which offers 3D mapping and real-time imaging capabilities. Another example is the ECGenius System, which provides remote catheter navigation and real-time ECG monitoring during ablation procedures. These technologies enhance the safety and effectiveness of AFib ablation strategies. However, the high cost of these devices can be a barrier for many hospitals and medical centers. Therefore, it is essential for institutions to explore various financing options, including leasing or renting, to make these advanced technologies accessible. By doing so, they can offer their patients the best possible care while managing their budgets effectively.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Atrial fibrillation (AF), a common heart rhythm disorder, affects millions worldwide, leading to increased demand for effective treatment options. The AF surgery market is witnessing significant growth due to the rising prevalence of cardiovascular disorders, such as myocarditis, atherosclerosis, and heart failure, which can cause AF. AF surgeries, including catheter ablation and surgical ablation, are increasingly being adopted to restore normal heart rhythm in patients. Regulatory policies and data requirements play a crucial role in the AF surgery market. Healthcare providers are focusing on advanced automotive features, such as remote patient monitoring and telehealth, to improve patient care and reduce hospital stays.
In addition, the geriatric population, who are more susceptible to AF due to age-related factors, is a significant target demographic. The competition in the AF surgery market is intense, with various surgical procedures, such as minimally invasive surgeries, offering advantages like accuracy, speedy recovery, and reduced surgical pain and injury. The high cost of AF therapeutics and regulatory issues surrounding these treatments pose challenges for market growth. Skilled labor and the need for customized services are other factors influencing market dynamics. AF surgery market participants must address the challenges of treating acute cardiac conditions, such as acute respiratory distress and acute cardiac shock, in AF patients. Stroke, AVNRT, and other rhythm disturbances are also common in AF patients, necessitating effective diagnostic tools and ablation strategies. ECG, Cathvision, ECGenius System, and other diagnostic technologies are essential in the AF surgery market.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
142 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 14.76% |
|
Market growth 2024-2028 |
USD 1.99 billion |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
12.55 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 39% |
|
Key countries |
US, China, UK, Germany, and Japan |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Abbott Laboratories, AngioDynamics Inc., AtriCure Inc., Avanos Medical Inc., BIOTRONIK SE and Co. KG, Boehringer Ingelheim International GmbH, Boston Scientific Corp., CardioFocus Inc., General Electric Co., Johnson and Johnson Services Inc., Koninklijke Philips N.V., Lepu Medical Technology Beijing Co. Ltd., Medtronic Plc, MicroPort Scientific Corp., OSYPKA AG, Siemens Healthineers AG, Stereotaxis Inc., Teleflex Inc., and Tempus Labs Inc. |
|
Market dynamics |
Parent market analysis, market growth inducers and obstacles, market forecast, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, market condition analysis for the forecast period |
|
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
